You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

T lymphocyte

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hepatocellular Carcinoma Trial in Yichang (Sintilimab)

Recruiting
  • Hepatocellular Carcinoma
  • Yichang, Hubei, China
    Department of Medical Oncology, Central Hospital of Yichang City
Sep 1, 2023

MDR-TB, Immunotherapy Trial in Shanghai (V?2Vd2 T lymphocyte-based immunotherapy, Treatment regimens for MDR-TB)

Recruiting
  • MDR-TB
  • Immunotherapy
  • Vγ2Vδ2 T lymphocyte-based immunotherapy
  • Treatment regimens for MDR-TB
  • Shanghai, China
  • +1 more
Aug 8, 2022

COL6A3 Positive, HLA-A*0201 Positive Cells Present, PRAME Positive Trial in Houston (biological, drug, procedure)

Active, not recruiting
  • COL6A3 Positive
  • +3 more
  • Aldesleukin
  • +4 more
  • Houston, Texas
    M D Anderson Cancer Center
Sep 22, 2022

T Cell Lymphoma, T-cell Leukemia Trial in Beijing (Efficacy of LCAR-T2C CAR-T cells)

Terminated
  • T Cell Lymphoma
  • T-cell Leukemia
  • Efficacy of LCAR-T2C CAR-T cells
  • Beijing, Beijing, China
  • +1 more
Aug 12, 2022

GVHD Trial in Ramat Gan (Cyclophosphamide, anti-human T-lymphocyte immunoglobulin (ATLG))

Recruiting
  • Graft Versus Host Disease
  • Ramat Gan, Israel
    Chaim Sheba Medical Center
May 4, 2022

Healthy Volunteers Trial in Paris (Collection of mobilized hematopoietic stem cells (apheresis products) from healthy

Recruiting
  • Healthy Volunteers
  • Collection of mobilized hematopoietic stem cells (apheresis products) from healthy volunteers
  • Paris, France
    CIC Paris Est, Hôpital Pitié Salpêtrière
Jun 8, 2022

CTLA4 Haploinsufficency, Chronic Cytopenia Trial run by the National Institute of Allergy and Infectious Diseases (NIAID)

Recruiting
  • CTLA4 Haploinsufficency
  • Chronic Cytopenia
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Aug 24, 2022

Hematopoietic Organs; Disorder Trial in Hong Kong (CD62L depleted donor lymphocyte infusion)

Recruiting
  • Hematopoietic Organs; Disorder
  • CD62L depleted donor lymphocyte infusion
  • Hong Kong, Hong Kong
    Hong Kong Children's Hospital
Sep 6, 2023

Glioblastoma, Malignant Glioma, Recurrent Glioblastoma Trial in Boston (CARv3-TEAM-E T cells)

Not yet recruiting
  • Glioblastoma
  • +3 more
  • CARv3-TEAM-E T cells
  • Boston, Massachusetts
    Massachusetts General Hospital Cancer Center
Dec 13, 2022

De Novo Kidney Transplant Patients Trial in China (ATG-F)

Completed
  • De Novo Kidney Transplant Patients
  • Beijing, China
  • +13 more
Jul 26, 2022

Recurrent Glioblastoma Trial (Targeted Epidermal Growth Factor Receptor Variant III(EGFRvIII) autochimeric antigen receptor T

Not yet recruiting
  • Recurrent Glioblastoma
  • Targeted Epidermal Growth Factor Receptor Variant III(EGFRvIII) autochimeric antigen receptor T cell injection
  • (no location specified)
Apr 4, 2023

Multiple Myeloma, Allogeneic Stem Cell Transplantation Trial in Spain (CARTemis-1)

Not yet recruiting
  • Multiple Myeloma
  • Allogeneic Stem Cell Transplantation
  • CARTemis-1
  • Santander, Cantabria, Spain
  • +4 more
Aug 1, 2023

Late Toxicities After Radiotherapy in Breast and Prostate Cancer

Completed
  • Breast Cancer
  • Prostate Cancer
    • Montpellier, France
      CRLC Val d'Aurelle
    Nov 29, 2022

    Myeloid Diseases Trial in Middletown, New York (drug, radiation, procedure)

    Recruiting
    • Myeloid Diseases
    • Antithymocyte globulin (Rabbit)
    • +5 more
    • Middletown, New Jersey
    • +1 more
    Jan 19, 2023

    Acute Lymphoid Leukemia (ALL), Acute Myeloid Leukemia (AML), Chronic Myeloid Leukemia (CML) Trial in New York (radiation, drug,

    Active, not recruiting
    • Acute Lymphoid Leukemia (ALL)
    • +5 more
    • Hyperfractionated total body irradiation
    • +9 more
    • New York, New York
      Memorial Sloan Kettering Cancer Center
    Jan 21, 2022

    Moderate COVID-19-infection Trial in Cologne (human SARS-CoV 2 specific T lymphocytes)

    Terminated
    • Moderate COVID-19-infection
    • human SARS-CoV 2 specific T lymphocytes
    • Cologne, NRW, Germany
      Department I for Internal Medicine University Hospital of Cologn
    Sep 12, 2022

    B-cell Acute Lymphoblastic Leukemia, B-cell Non Hodgkin Lymphoma Trial in Aurora (CD19CAR-CD3Zeta-4-1BB-Expressing Autologous

    Recruiting
    • B-cell Acute Lymphoblastic Leukemia
    • B-cell Non Hodgkin Lymphoma
    • CD19CAR-CD3Zeta-4-1BB-Expressing Autologous T-Lymphocyte Cells
    • Aurora, Colorado
      Children's Hospital Colorado
    Nov 9, 2022

    Hematologic Malignancy Trial in Tuebingen,, Tuebingen (CD45RA depleted donor lymphocyte infusion (DLI))

    Recruiting
    • Hematologic Malignancy
    • CD45RA depleted donor lymphocyte infusion (DLI)
    • Tuebingen,, Germany
    • +1 more
    Jul 13, 2023

    T-Cell Large Granular Lymphocyte Leukemia Trial in Columbus (Ruxolitinib)

    Not yet recruiting
    • T-Cell Large Granular Lymphocyte Leukemia
    • Columbus, Ohio
      Ohio State University Comprehensive Cancer Center
    Oct 20, 2022

    Metastatic Malignant Tumor in the Liver, Metastatic Uveal Melanoma Trial in Houston (Aldesleukin, Autologous CD8+

    Active, not recruiting
    • Metastatic Malignant Neoplasm in the Liver
    • Metastatic Uveal Melanoma
    • Aldesleukin
    • +3 more
    • Houston, Texas
      M D Anderson Cancer Center
    Jan 20, 2023

    Lymphoid Leukemia, Acute, Myeloid Malignancy, Plasma Cell Tumor Trial in Miami (T-cell Receptor a/ß Depleted Donor Lymphocyte

    Recruiting
    • Lymphoid Leukemia, Acute
    • +2 more
    • T-cell Receptor α/β Depleted Donor Lymphocyte Infusions
    • Miami, Florida
      Miami Cancer Institute at Baptist Health, Inc
    May 24, 2022

    Non-hodgkin Lymphoma,B Cell Trial (CD19-targeted non-viral PD1 site-specific integrated CAR-T cell injection)

    Not yet recruiting
    • Non-hodgkin Lymphoma,B Cell
    • CD19-targeted non-viral PD1 site-specific integrated CAR-T cell injection
    • (no location specified)
    Feb 14, 2023

    Pleural Biphasic Mesothelioma, Pleural Sarcomatoid Mesothelioma Trial (Nivolumab, Ipilimumab, Surgical Procedure)

    Not yet recruiting
    • Pleural Biphasic Mesothelioma
    • Pleural Sarcomatoid Mesothelioma
    • Nivolumab
    • +5 more
    • (no location specified)
    Dec 9, 2022

    Relapsed or Advanced Gastric Adenocarcinoma, Gastro-esophageal Junction Cancer Trial in Seoul (autologous activated T

    Recruiting
    • Relapsed or Advanced Gastric Adenocarcinoma
    • Gastro-esophageal Junction Cancer
    • autologous activated T lymphocyte
    • Seoul, Korea, Republic of
      Gangnam Severacen Hospital
    Sep 15, 2021

    CD4+T Lymphocytes in Primary Nephrotic Syndrome With Infection

    Recruiting
    • Nephrotic Syndrome
    • +2 more
    • The study is an observational study without intervention
    • Zhuhai, Guangdong, China
      the fifth affiliated hospital of SUN YAT-SEN university
    Nov 20, 2022